# Surgicure Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/surgicure-technologies

- Industry: Healthcare
- Headquarters: Charlestown, US
- Website: www.surgicuretech.com
- Total disclosed funding: $1.8M
- Latest round: Seed (Mar 12, 2025)
- Investors on record: 9

## About

Surgicure Technologies, Inc. is a US-based company dedicated to developing innovative solutions for enhancing medical care, particularly through improved securement of endotracheal tubes. Its patented technology significantly reduces risks associated with facial pressure injuries and improves patient comfort.Founded in 2018 in Charlestown, US, Surgicure Technologies, Inc. specializes in medical innovations aimed at enhancing patient care. The company was founded by Irena King, who has a background in medical technology. In March 2025, Surgicure raised USD 1.785 mn in a Seed round, led by Launchpad Venture Group, with participation from several investors including Gurtin Ventures and TiE Angels. The total amount raised by the company to date is USD 1.785 mn with a current valuation of USD 5.695 mn.Surgicure Technologies, Inc. offers a patented solution aimed at securing endotracheal (ET) tubes, minimizing facial pressure injuries, and improving oral care for patients. This product is essential in intensive care and surgical settings, addressing key challenges faced by healthcare providers. The company serves hospitals and medical facilities particularly in North America and Europe, where there is a growing demand for innovative healthcare solutions.Surgicure Technologies, Inc. generates revenue through a direct-to-consumer model, selling its ET tube securement device to healthcare institutions. The company anticipates that its flagship product will become standard practice in hospitals, resulting in consistent purchase orders. Transactions are typically governed by contractual agreements with hospitals, which outline terms for bulk purchases and ongoing support, tailored to meet their diverse needs.As of March 2025, Surgicure Technologies, Inc. plans to utilize its recent Seed funding of USD 1.785 mn to accelerate the commercialization of its patented ET tube securement solution. The company aims to enhance patient care quality and safety across various medical settings. Future initiatives include introducing additional product innovations and expanding its market presence in North America and Europe, striving to be a key player in the medical solutions industry.

## Funding rounds

- Seed, Mar 12, 2025, $1.8M — Launchpad Venture Group, TiE Angels, Beacon Angels, SideCar Angels, Gurtin Ventures, Tidal River Fund, SBXi, BBE Ventures, BakerBridge Capital

## Investors

- Launchpad Venture Group (https://capitalatlas.ai/funds/launchpad-venture-group) — Seed
- TiE Angels (https://capitalatlas.ai/funds/tie-angels) — Seed
- Beacon Angels (https://capitalatlas.ai/funds/beacon-angels) — Seed
- SideCar Angels (https://capitalatlas.ai/funds/sidecar-angels) — Seed
- Gurtin Ventures (https://capitalatlas.ai/funds/gurtin-ventures) — Seed
- Tidal River Fund (https://capitalatlas.ai/funds/tidal-river-fund) — Seed
- SBXi (https://capitalatlas.ai/funds/sbxi) — Seed
- BBE Ventures — Seed
- BakerBridge Capital (https://capitalatlas.ai/funds/bakerbridge-capital) — Seed